Published on 11 September 2023
Description:
Accelerating clinical trial diversity; the fight against AMR; innovation in chronic diseases; the importance of actinic keratosis awareness
Categories:
Pharmaceutical Market Europe32 articles from this collection:
PME September 2023
2 - PME
3 - Comment
4 - PMEA 2023
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Dermatology news
12 - DARWIN'S MEDICINE - Dollo's law
12 - Pharma Market Europe Darwin’s medicine
13 - POLICY AND PUBLIC HEALTH - The paper trail
14 - MIKE DIXON - Being healthy
15 - INNOVATIVE IMPACT BLOG - Seven steps to exceptional launches
16-17 - PROSTATE CANCER - The impact of prostate cancer on global health
18-19 - ANTIMICROBIAL RESISTANCE - Man vs microbe: the fight against antimicrobial resistance
20-21 - ACTINIC KERATOSIS - Actinic keratosis – a common skin condition that can lead to skin cancer
22-23 - TL HAVAS GROUP - Lean on ‘We’: Point.1 – HCP data with purpose and perception
24-26 - CHRONIC DISEASES - The five ‘innovation areas’ driving success in chronic diseases
27 - TL ASTRA ZENECA - Harnessing innovation to change the future of chronic diseases in Europe
28 - TL INIZIO - Improvement in rare disease diagnosis and care
29 - PME highlights
30-32 - DIVERSITY IN CLINICAL TRIALS - The importance of accelerating clinical trial diversity
32 - TL EVOKE - Driving market access through clinical trial diversity
33 - TL HAVAS LYNX FAZE - Diversity and inclusion in clinical trials: keeping up momentum
34-35 - AI AND CLINICAL TRIALS - Harnessing the power of AI in clinical trials
36 - TL BCMS - How to create value in your business
37 - RARE DISEASES - LifeArc to launch rare disease centres across the UK
37 - GEORGE BUCKLAND
38-40 - Appointments
41 - HEALTHCARE COMMS
42 - PHARMATIMES MARKETERS, COMMUNICATIONS and SALES
43 - PHARMAROLE
44 - FLYPHARMA EUROPE
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services